Nuritas combines artificial intelligence and genomics to discover and unlock natural Bioactive Peptides with extraordinary health benefits

Dr Nora Khaldi

Founder and CSO

Nora is a mathematician with a PhD in Molecular Evolution and Bioinformatics. Nora’s research has focused primarily on protein evolution and comparative genomics.

Some of Nora’s publications have been placed in a library of the top 2% of published articles in the fields of biology and medicine.

Throughout her career, Nora’s ambition has been to disrupt the status quo in areas that have been void of technology by introducing new ways of thinking, big data, and new algorithms.

Previous to Nuritas™, Nora was the first scientist to show gene transfer between multi-cellular species. This groundbreaking find put into question many of the phylogenetic methods currently in use today.

Nora has developed a multitude of innovative software throughout her research career that are used to this day by research institutes and companies in over 70 countries. Nora has led international research teams around the world, in both academic and industrial settings, and has a proven record in new health-benefiting molecule discovery and commercialisation.

Over the next few years, Nora plans to lead the Nuritas™ team in their goal of reaching billions of people with their life-changing ingredients.

Emmet Browne

CEO

Emmet Browne holds more than 25 years of international experience within some of the world’s largest Life-Science companies. He has held senior positions including Regional President at Pfizer Nutritionals for Europe, Pacific Rim & Emerging Markets, Managing Director for Wyeth Pharmaceuticals in Ireland and President of Transition and Integration for Nestle based in their Global HQ in Vevey, Switzerland.

He played a key role within the Pfizer Nutrition core leadership team in preparation for and the successful divestment to Nestlé for $11.85 billion in 2012. Emmet is the former Chairman of the Blanchardstown Institute of Technology and was Vice President of the Irish Pharmaceutical Healthcare Association.

Emmet joined Nuritas™ as CEO in March 2015 and looks forward to making it the world’s largest discoverer and developer of bioactive peptides. He has worked new starts, turnarounds, and takeovers whilst consistently delivering continued growth through people and great science. With decades of experience in the life science/human nutrition area he recognized the great potential of Nuritas™ to develop into a thriving commercial success, which will have a real societal impact globally through the creation of life-changing ingredients.

Greg Stafford

CFO

Greg Stafford has had extensive experience working in various managerial and advisory roles within both small and multinational organizations such as KPMG, Paddy Power/Betfair, Vodafone and Hutchison Whampoa Joint Venture.

He holds a Bachelor of Commerce degree from University College Dublin (UCD) as well as a Master of Accounting from Smurfit College. He is a charted accountant (ACA) and a member of the Institute of Chartered Accountants Ireland.

Greg has gained a vast amount of knowledge from his work in a wide range of industries. Notably, banking, investment management, insurance, venture capital, telecommunications, and technology. As a result of this, he has a wide breadth of experience in process implementation and improvement whilst adhering to global best practices, including SOX compliance.

Furthermore, he has experience in growing both a finance function and an organization to achieve scale and ensure a strong basis for developing talent.

During his earlier career in sports, Greg represented his country at numerous levels of rugby. As a result of this background, he has a strong commitment to teamwork and utilising the skill sets off all members of a team.

Bernard Keogh

General Counsel

Bernard Keogh has over 25 years’ experience in the technology and communications industries.

Prior to joining Nuritas, Bernard was a senior adviser at Granahan McCourt, a private investment firm focused on connecting people to innovation in technologically underserved areas of the world. He served as General Counsel of enet, the leading wholesale communications provider in Ireland, and sat on the boards of several other entities in which Granahan McCourt held investments.

Previously, Bernard held leadership roles with global communications firms Level 3 and Global Crossing. He was General Counsel at ComReg, regulator of the communications and postal sectors in Ireland, and held various roles at William Fry, a leading international law firm.